Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Contribution of pannexin1 to experimental autoimmune encephalomyelitis.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Teriflunomide for the treatment of multiple sclerosis.
Aberrant Type I Interferon Regulation in Autoimmunity: Opposite Directions in MS and SLE, Shaped by Evolution and Body Ecology.
The stress-buffering effects of hope on changes in adjustment to caregiving in multiple sclerosis.
Non-protein amino acids and neurodegeneration: The enemy within.
Upregulation of ciliary neurotrophic factor in astrocytes by aspirin: Implications for remyelination in multiple sclerosis.
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance.
MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.
MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Pregnancy Does Not Prove Neuroprotective for Women with MS Who Stop Taking Natalizumab
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.
Psychological well-being in people with multiple sclerosis in an Iranian population.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Pages
« first
‹ previous
…
509
510
511
512
513
514
515
516
517
…
next ›
last »